Kirsty Brittain1,2, Claude A Mellins3, Robert H Remien3, Tamsin K Phillips1,2, Allison Zerbe4, Elaine J Abrams4,5, Landon Myer1,2. 1. Division of Epidemiology and Biostatistics, School of Public Health and Family Medicine, University of Cape Town, Cape Town, South Africa. 2. Centre for Infectious Disease Epidemiology and Research, School of Public Health and Family Medicine, University of Cape Town, Cape Town, South Africa. 3. HIV Center for Clinical and Behavioral Studies, New York State Psychiatric Institute, Columbia University, New York, NY. 4. Mailman School of Public Health, ICAP at Columbia University, New York, NY. 5. Vagelos College of Physicians and Surgeons, Columbia University, New York, NY.
Abstract
BACKGROUND: HIV-status disclosure is widely encouraged by counseling services, in part because it is thought to improve antiretroviral therapy (ART) adherence and thus HIV viral suppression. However, few longitudinal studies have examined the impact of disclosure on HIV viral load (VL) during pregnancy and postpartum. METHODS: We explored these associations among 1187 women living with HIV, enrolled between March 2013 and June 2014 in Cape Town, South Africa. RESULTS: Among women who tested HIV-positive before pregnancy, we observed no association between disclosure and VL at entry into antenatal care among those already on ART, nor at delivery and 12 months postpartum among those initiating ART. Among women who tested HIV-positive during pregnancy and initiated ART subsequently, disclosure to a male partner was associated with a reduced risk of VL ≥50 copies/mL at delivery (adjusted risk ratio: 0.56; 95% confidence interval: 0.31 to 1.01). After stratification by relationship status, this association was only observed among women who were married and/or cohabiting. In addition, disclosure to ≥1 family/community member was associated with a reduced risk of VL ≥50 copies/mL at 12 months postpartum (adjusted risk ratio: 0.69; 95% confidence interval: 0.48 to 0.97) among newly-diagnosed women. CONCLUSIONS: These findings suggest that the impact of disclosure on VL is modified by 3 factors: (1) timing of HIV diagnosis (before vs. during the pregnancy); (2) relationship to the person(s) to whom women disclose; and (3) in the case of disclosure to a male partner, relationship status. Counseling about disclosure may be most effective if tailored to individual women's circumstances.
BACKGROUND: HIV-status disclosure is widely encouraged by counseling services, in part because it is thought to improve antiretroviral therapy (ART) adherence and thus HIV viral suppression. However, few longitudinal studies have examined the impact of disclosure on HIV viral load (VL) during pregnancy and postpartum. METHODS: We explored these associations among 1187 women living with HIV, enrolled between March 2013 and June 2014 in Cape Town, South Africa. RESULTS: Among women who tested HIV-positive before pregnancy, we observed no association between disclosure and VL at entry into antenatal care among those already on ART, nor at delivery and 12 months postpartum among those initiating ART. Among women who tested HIV-positive during pregnancy and initiated ART subsequently, disclosure to a male partner was associated with a reduced risk of VL ≥50 copies/mL at delivery (adjusted risk ratio: 0.56; 95% confidence interval: 0.31 to 1.01). After stratification by relationship status, this association was only observed among women who were married and/or cohabiting. In addition, disclosure to ≥1 family/community member was associated with a reduced risk of VL ≥50 copies/mL at 12 months postpartum (adjusted risk ratio: 0.69; 95% confidence interval: 0.48 to 0.97) among newly-diagnosed women. CONCLUSIONS: These findings suggest that the impact of disclosure on VL is modified by 3 factors: (1) timing of HIV diagnosis (before vs. during the pregnancy); (2) relationship to the person(s) to whom women disclose; and (3) in the case of disclosure to a male partner, relationship status. Counseling about disclosure may be most effective if tailored to individual women's circumstances.
Authors: Oladele Vincent Adeniyi; Anthony Idowu Ajayi; Nonkosi Selanto-Chairman; Daniel Ter Goon; Gerry Boon; Yusimi Ordaz Fuentes; George Justus Hofmeyr; Gordana Avramovic; Craig Carty; John Lambert Journal: PLoS One Date: 2017-08-24 Impact factor: 3.240
Authors: Matilda Ngarina; Rebecca Popenoe; Charles Kilewo; Gunnel Biberfeld; Anna Mia Ekstrom Journal: BMC Public Health Date: 2013-05-07 Impact factor: 3.295
Authors: Landon Myer; Tamsin K Phillips; Allison Zerbe; Kirsty Brittain; Maia Lesosky; Nei-Yuan Hsiao; Robert H Remien; Claude A Mellins; James A McIntyre; Elaine J Abrams Journal: PLoS Med Date: 2018-03-30 Impact factor: 11.069
Authors: Wenwen Jiang; Lusi Osborn; Alison L Drake; Jennifer A Unger; Daniel Matemo; John Kinuthia; Grace John-Stewart; Keshet Ronen Journal: J Assoc Nurses AIDS Care Date: 2021 Mar-Apr 01 Impact factor: 1.809
Authors: Megan Landes; Monique van Lettow; Joep J van Oosterhout; Erik Schouten; Andrew Auld; Thokozani Kalua; Andreas Jahn; Beth A Tippett Barr Journal: PLoS One Date: 2021-03-12 Impact factor: 3.240
Authors: Julianne Meisner; D Allen Roberts; Patricia Rodriguez; Monisha Sharma; Morkor Newman Owiredu; Bertha Gomez; Maeve B de Mello; Alexey Bobrik; Arkadii Vodianyk; Andrew Storey; George Githuka; Thato Chidarikire; Ruanne Barnabas; Shiza Farid; Shaffiq Essajee; Muhammad S Jamil; Rachel Baggaley; Cheryl Johnson; Alison L Drake Journal: J Int AIDS Soc Date: 2021-04 Impact factor: 5.396
Authors: Florence M Momplaisir; Tanner Nassau; Kari Moore; Clara Grayhack; Wanjiku F M Njoroge; Ana V Diez Roux; Kathleen A Brady Journal: JAMA Netw Open Date: 2020-11-02